286 related articles for article (PubMed ID: 32968642)
1. Implications of gut microbiome on coronary artery disease.
Xu J; Yang Y
Cardiovasc Diagn Ther; 2020 Aug; 10(4):869-880. PubMed ID: 32968642
[TBL] [Abstract][Full Text] [Related]
2. The Role of Gut Microbiota and Trimethylamine N-oxide in Cardiovascular Diseases.
Huang Y; Zhang H; Fan X; Wang J; Yin Y; Zhang Y; Shi K; Yu F
J Cardiovasc Transl Res; 2023 Jun; 16(3):581-589. PubMed ID: 36251229
[TBL] [Abstract][Full Text] [Related]
3. Diet-gut microbiota interactions on cardiovascular disease.
Zhang X; Gérard P
Comput Struct Biotechnol J; 2022; 20():1528-1540. PubMed ID: 35422966
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?
Cao H; Zhu Y; Hu G; Zhang Q; Zheng L
Pharmacol Res; 2023 Jan; 187():106586. PubMed ID: 36460280
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic Review on the Role of Gut Microbiota in the Pathology of Cardiovascular Diseases.
Usman I; Anwar A; Shukla S; Pathak P
Cardiovasc Hematol Disord Drug Targets; 2024 Jun; ():. PubMed ID: 38879769
[TBL] [Abstract][Full Text] [Related]
6. Gut macrobiotic and its metabolic pathways modulate cardiovascular disease.
Zhu J; Lyu J; Zhao R; Liu G; Wang S
Front Microbiol; 2023; 14():1272479. PubMed ID: 37822750
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota metabolic characteristics in coronary artery disease patients with hyperhomocysteine.
Tian R; Liu HH; Feng SQ; Wang YF; Wang YY; Chen YX; Wang H; Zhang SY
J Microbiol; 2022 Apr; 60(4):419-428. PubMed ID: 35246806
[TBL] [Abstract][Full Text] [Related]
8. The Role of Gut Microbiota and Associated Compounds in Cardiovascular Health and its Therapeutic Implications.
Liu L; Kaur GI; Kumar A; Kanwal A; Singh SP
Cardiovasc Hematol Agents Med Chem; 2024 Jan; ():. PubMed ID: 38275032
[TBL] [Abstract][Full Text] [Related]
9. Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease.
Al Samarraie A; Pichette M; Rousseau G
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982492
[TBL] [Abstract][Full Text] [Related]
10. Could Artificial Intelligence/Machine Learning and Inclusion of Diet-Gut Microbiome Interactions Improve Disease Risk Prediction? Case Study: Coronary Artery Disease.
Vilne B; Ķibilds J; Siksna I; Lazda I; Valciņa O; Krūmiņa A
Front Microbiol; 2022; 13():627892. PubMed ID: 35479632
[TBL] [Abstract][Full Text] [Related]
11. Gut Dysbiosis and Immune System in Atherosclerotic Cardiovascular Disease (ACVD).
Yoo JY; Sniffen S; McGill Percy KC; Pallaval VB; Chidipi B
Microorganisms; 2022 Jan; 10(1):. PubMed ID: 35056557
[TBL] [Abstract][Full Text] [Related]
12. The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation.
Rahman MM; Islam F; -Or-Rashid MH; Mamun AA; Rahaman MS; Islam MM; Meem AFK; Sutradhar PR; Mitra S; Mimi AA; Emran TB; Fatimawali ; Idroes R; Tallei TE; Ahmed M; Cavalu S
Front Cell Infect Microbiol; 2022; 12():903570. PubMed ID: 35795187
[TBL] [Abstract][Full Text] [Related]
13. Diversified Shifts in the Cross Talk between Members of the Gut Microbiota and Development of Coronary Artery Diseases.
Zhang T; Ren H; Du Z; Zou T; Guang X; Zhang Y; Tian Y; Zhu L; Yu J; Yu X; Zhang Z; Dai H
Microbiol Spectr; 2022 Dec; 10(6):e0280422. PubMed ID: 36301099
[TBL] [Abstract][Full Text] [Related]
14. Update on gut microbiota in cardiovascular diseases.
Qian B; Zhang K; Li Y; Sun K
Front Cell Infect Microbiol; 2022; 12():1059349. PubMed ID: 36439214
[TBL] [Abstract][Full Text] [Related]
15. Research development on gut microbiota and vulnerable atherosclerotic plaque.
Zheng S; Liu Z; Liu H; Lim JY; Li DWH; Zhang S; Luo F; Wang X; Sun C; Tang R; Zheng W; Xie Q
Heliyon; 2024 Feb; 10(4):e25186. PubMed ID: 38384514
[TBL] [Abstract][Full Text] [Related]
16. The Gut-Heart Axis: Updated Review for The Roles of Microbiome in Cardiovascular Health.
Bui TVA; Hwangbo H; Lai Y; Hong SB; Choi YJ; Park HJ; Ban K
Korean Circ J; 2023 Aug; 53(8):499-518. PubMed ID: 37525495
[TBL] [Abstract][Full Text] [Related]
17. Microbial metabolites and heart failure: Friends or enemies?
Lu X; Liu J; Zhou B; Wang S; Liu Z; Mei F; Luo J; Cui Y
Front Microbiol; 2022; 13():956516. PubMed ID: 36046023
[TBL] [Abstract][Full Text] [Related]
18. Role of gut microbiota in cardiovascular diseases.
Novakovic M; Rout A; Kingsley T; Kirchoff R; Singh A; Verma V; Kant R; Chaudhary R
World J Cardiol; 2020 Apr; 12(4):110-122. PubMed ID: 32431782
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota and cardiovascular disease: opportunities and challenges.
Kazemian N; Mahmoudi M; Halperin F; Wu JC; Pakpour S
Microbiome; 2020 Mar; 8(1):36. PubMed ID: 32169105
[TBL] [Abstract][Full Text] [Related]
20. The Microbial and Metabolic Signatures of Patients with Stable Coronary Artery Disease.
Zhong J; Wu D; Zeng Y; Wu G; Zheng N; Huang W; Li Y; Tao X; Zhu W; Sheng L; Shen X; Zhang W; Zhu R; Li H
Microbiol Spectr; 2022 Dec; 10(6):e0246722. PubMed ID: 36354350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
